Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5
- Resource Type
- Correspondence
- Source
- In
The Lancet Infectious Diseases October 2023 23(10):e395-e396 - Subject
Analysis and Interpretation Correspondence - Language
- ISSN
- 1473-3099